Federal Cannabis Employment Protections: Laws, Limits and Pending Bills
This hub explains where federal law stands on cannabis and employment. It covers federal civilian workers, security clearance holders, federal contractors, and DOT-regulated safety-sensitive employees. It also covers how state-level protections interact with federal rules. Cannabis remains a controlled substance under federal law, and no statute currently shields federal employees or most private workers from discipline for marijuana use. Congress periodically considers bills that would limit adverse employment actions tied to lawful state-legal use. CannIntel tracks those proposals, agency guidance such as security clearance policy, and court rulings. We update this page as legislation moves.

Executive summary
No federal statute currently protects any worker from being fired, refused a job, or denied a security clearance because of cannabis use, and a new bill in Congress aims to change that for federal employment. A Marijuana Moment newsletter dated September 21, 2026 flagged a cannabis-related federal employment bill. This hub covers the legal baseline that any such bill would amend, and we will append dated updates as the text and cosponsor list are confirmed.
Cannabis remains a Schedule I substance under 21 U.S.C. § 812, so federal employment law treats use as illegal drug use. Executive Order 12564 (1986) requires a drug-free federal workplace. The Drug-Free Workplace Act of 1988 binds federal contractors and grantees. The Department of Transportation's 49 CFR Part 40 mandates testing for safety-sensitive transportation workers. The Americans with Disabilities Act excludes current illegal drug use from its protections (42 U.S.C. § 12114).
States have filled the gap unevenly. California, New York, New Jersey, Washington, Nevada, Illinois, Connecticut, Minnesota and others now restrict employer action over lawful off-duty use or pre-employment screening. Texas, Ohio and Florida leave employers free to fire.
The result is a three-layer patchwork of federal baseline, sector mandates and state overlay. A federal employment bill would matter most for the federal workforce, security-clearance holders and agency hiring. It would matter much less for private employers or DOT-regulated workers unless it expressly reaches them.
Operators should treat the bill as a signal rather than a change in law. Nothing in this hub's baseline changes until a bill is enacted and implementing guidance issues.
Why this matters
Employment is where cannabis legalization most often collides with ordinary life, because about 40 states allow some form of legal use while federal rules still treat use as disqualifying. The conflict affects millions of workers, thousands of employers and every cannabis operator that hires.
Stakeholders and scale
- Federal employees and applicants. The civilian federal workforce numbers in the low millions, plus military personnel and contractors. All are subject to drug-free workplace rules, and many hold clearances.
- Federal contractors and grantees. The Drug-Free Workplace Act of 1988 (41 U.S.C. § 8102) requires a drug-free workplace policy as a condition of covered awards. It does not require testing.
- Safety-sensitive transportation workers. DOT-regulated employees in aviation, trucking, rail, transit, pipelines and maritime must pass drug tests with no medical-cannabis exception.
- Private employers. Most are governed by state law, which varies by state.
- Cannabis workers. Employees of licensed dispensaries and cultivators are often protected by state law because their jobs involve cannabis. They face their own federal exposure under 280E and banking limits.
The testing data
According to the Quest Diagnostics Drug Testing Index covering 2023, marijuana positivity in the combined U.S. workforce reached 4.5%, a record at the time. Positivity has risen as legalization has expanded. Employers therefore face a larger pool of candidates who test positive but are legal users under state law.
Dollars and operational risk
The exposure is practical. Employers in tight labor markets lose candidates over pre-employment urine screens that detect THC-COOH metabolites for days or weeks after use. Those metabolites do not show impairment. Agencies lose qualified applicants. Contractors face compliance risk if they set policies that conflict with a state anti-discrimination statute. A federal employment bill, if enacted, would be the first attempt to change that baseline nationally.
Background and history
Federal cannabis employment policy was built in the 1980s drug-war era and has changed mainly at the margins since, while state law moved far faster.
1970: The Controlled Substances Act
Congress placed marijuana in Schedule I when it enacted the Controlled Substances Act, codified in part at 21 U.S.C. § 812. Schedule I status means no accepted medical use and a high potential for abuse. Every later employment rule inherited that classification.
1986: Executive Order 12564
President Reagan signed Executive Order 12564 on September 15, 1986, declaring that federal employees must refrain from illegal drug use on or off duty. It authorized testing for employees in sensitive positions, applicants, and cases of reasonable suspicion. Section 503 of the Supplemental Appropriations Act of 1987 gave the testing program a statutory footing.
1988: The Drug-Free Workplace Act
Congress passed the Drug-Free Workplace Act of 1988, requiring federal contractors and grantees above specified thresholds to certify a drug-free workplace. Many private employers adopted testing in response, even though the law did not require it.
1990–1991: ADA and transportation testing
The Americans with Disabilities Act of 1990 excluded current illegal drug users from protection, a carve-out courts later applied to medical marijuana patients. The Omnibus Transportation Employee Testing Act of 1991 required testing across DOT-regulated industries, now implemented through 49 CFR Part 40.
1996–2012: State legalization begins
California's Proposition 215 (1996) created the first state medical program. Courts then confronted whether employers had to accommodate patients. In Ross v. RagingWire Telecommunications (California, 2008), the state supreme court held employers need not accommodate medical use. Emerald Steel Fabricators v. BOLI (Oregon, 2010) and Coats v. Dish Network (Colorado, 2015) reached similar results. Colorado and Washington legalized adult use in 2012.
2005: Gonzales v. Raich
In Gonzales v. Raich, 545 U.S. 1 (2005), the Supreme Court held Congress may regulate even home-grown medical marijuana under the Commerce Clause. The decision anchors the principle that state legalization does not change federal law.
2014: Appropriations rider and clearance memo
The Rohrabacher-Farr amendment, enacted in the 2015 appropriations law, barred the Justice Department from spending funds to interfere with state medical programs. The Ninth Circuit applied it in United States v. McIntosh (2016). It protects state-compliant operators from prosecution but does not protect employees from termination. In November 2014, the Director of National Intelligence issued a memo stating that marijuana use remains relevant to clearance decisions regardless of state law.
2017: Barbuto and SEAD 4
In Barbuto v. Advantage Sales & Marketing (2017), the Massachusetts Supreme Judicial Court held that a medical marijuana patient fired over a positive test could bring a handicap-discrimination claim. It was a rare court-driven accommodation. The same year, Security Executive Agent Directive 4 consolidated the adjudicative guidelines, including Guideline H on drug involvement.
2019–2021: State anti-discrimination wave
Nevada passed AB 132 in 2019, restricting pre-employment screening for marijuana in most jobs. New York amended Labor Law § 201-d in 2019, and its 2021 Marihuana Regulation and Taxation Act protected lawful off-duty use. New Jersey's CREAMMA (2021) barred adverse action based solely on a positive test. Connecticut enacted similar protections in 2021. Virginia protected certified medical patients in 2021.
2021: The Haines memo
On December 21, 2021, DNI Avril Haines issued guidance stating that past marijuana use should not by itself be determinative in clearance decisions, and that agencies should weigh the whole person. Use while holding a clearance remained a concern. The memo softened practice without changing the rule.
2022–2023: Pardons and Schedule III proposal
President Biden pardoned federal simple-possession offenses on October 6, 2022 and expanded relief on December 22, 2023. In May 2024, the DOJ and DEA published an NPRM to move marijuana to Schedule III. The DEA's administrative hearing before an ALJ was scheduled for early 2025 and then stayed.
2023–2024: Newer state laws
California's AB 2188 and SB 700 took effect January 1, 2024. They bar discrimination for off-duty use and prohibit inquiries about prior use. Washington's SB 5123 banned most pre-employment screening from January 1, 2024. Minnesota's 2023 law expanded workplace protections.
2025: Executive order and hemp redefinition
On December 18, 2025, President Trump signed an executive order directing the Attorney General to expedite rescheduling to Schedule III. In November 2025, a federal appropriations law redefined hemp to cap total THC per container, with an effective date one year after enactment (around mid-November 2026). That change affects hemp-derived products such as delta-8 THC and THCA flower that employees use and that can trigger positive tests. Readers should confirm the current rescheduling status, since it may have moved since this foundation was written.
September 2026: The employment bill
Marijuana Moment's September 21, 2026 newsletter listed a cannabis and federal employment bill in Congress among the week's items. We have not independently confirmed its sponsor, bill number, or text beyond that headline, and this hub will be updated once those details are verified.
Key players
Authority over cannabis employment rules is split among Congress, the White House, personnel and intelligence agencies, DOT, state legislatures and advocacy groups.
Congress
Congress holds the pen on any statutory change. Relevant committees include House Oversight and Government Reform and Senate Homeland Security and Governmental Affairs for federal personnel, and the Judiciary committees for scheduling and the CSA. Appropriations riders have been the most effective vehicle for incremental cannabis change, which makes the appropriations process a likelier path than a standalone bill.
Office of Personnel Management
OPM administers suitability and fitness rules for competitive-service hiring and issues guidance to agencies. It has historically advised that federal employees remain bound by the Controlled Substances Act regardless of state law.
Office of the Director of National Intelligence
Frequently asked questions
Can federal employees legally use marijuana?
No. Because cannabis is still a Schedule I controlled substance under the Controlled Substances Act, federal agencies treat use as incompatible with federal employment. Executive Order 12564 (1986) established a drug-free federal workplace, and it applies even when an employee lives in a state with legal adult-use or medical programs. Agencies may test employees in designated positions and discipline those who use.
Is there a federal law protecting workers who use cannabis off duty?
No. No federal statute prohibits employers from firing or refusing to hire someone for cannabis use. The Americans with Disabilities Act does not protect medical marijuana use because it excludes current illegal drug use as defined by federal law. Protections come mainly from state laws, which vary widely.
What does the federal employment bill in Congress do?
Reporting from Marijuana Moment's September 21, 2026 newsletter flags a cannabis-related federal employment bill in Congress. Proposals of this kind generally aim to limit adverse employment actions for lawful or past cannabis use. Check the bill text on Congress.gov for its exact scope, sponsors, and status. A bill is not law until both chambers pass it and the President signs it.
Does marijuana use disqualify someone from a security clearance?
Not automatically, but it is a concern. Security Executive Agent Directive 4 (SEAD 4) lists drug involvement as an adjudicative guideline. A December 2021 memo from the Director of National Intelligence said past marijuana use should not by itself be disqualifying. Current use remains a problem, and agencies weigh recency, frequency, and willingness to stop.
Do federal contractors have to drug test employees?
Not necessarily. The Drug-Free Workplace Act of 1988 requires covered contractors and grantees to maintain a drug-free workplace policy, give employees notice, and set up awareness programs. It does not itself mandate testing. Specific contracts, agency rules, or safety-sensitive roles may require testing, and cannabis remains a prohibited substance.
Can DOT-regulated workers use medical marijuana?
No. Under 49 CFR Part 40, the Department of Transportation tests safety-sensitive employees such as pilots, truckers, and transit operators for marijuana. The DOT has said that a state medical marijuana authorization is not a valid medical explanation for a positive result. Medical review officers must verify such results as positive.
Do state cannabis employment protections apply to federal employees?
Generally no. State laws such as New York Labor Law 201-d, California's AB 2188, and New Jersey's CREAMMA limit private employers from acting on lawful off-duty use or certain pre-employment tests. Under the Supremacy Clause, federal agencies follow federal law. Federal contractors and federally mandated testing programs are also often exempt from state protections.
Would rescheduling marijuana protect employees?
Not by itself. Moving cannabis to Schedule III would change its federal regulatory status but would not automatically create employment protections. Non-prescribed use would likely remain unlawful under federal law. Employers and agencies could still maintain drug-free workplace policies and testing programs unless Congress or agencies change those rules.
Can hemp or CBD products cause a failed drug test?
Yes. Federal law allows hemp with no more than 0.3% delta-9 THC, but full-spectrum CBD products can contain trace THC. Regular use may produce a positive screen, especially at higher doses. Mislabeled products are another risk. Federal testing programs generally do not accept CBD use as an excuse for a positive THC result.
What should workers in legal states know about cannabis and jobs?
Check your state's employment statute, your employer's written policy, and whether federal rules apply to your role. Even where state law protects off-duty use, employers can usually ban impairment at work. Safety-sensitive roles, federal contracts, and DOT-regulated jobs often fall outside state protections. Consult an employment attorney for specific situations.
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.